Weight Management & Obesity

Energy balance, GLP‑1 medications, sustainable loss, and weight stigma topics.

  • 4 Tracked terms
  • Last 30 days Feed window

What this topic collects on

An article joins this feed when it matches these terms. Each one is also a search of its own.

Latest in Weight Management & Obesity


blackdoctor.com > when-weight-bias-delays-a-diagnosis

When Weight Bias Delays a Diagnosis, Here’s How Black Patients Can Self-Advocate

58+ min ago   (425+ words) RELATED: Weightism: Is Weight Bias Just As Harmful as Obesity? When seeking medical intervention, people with obesity have reported being mistreated, ignored, or denied care entirely. As a result, some of them don’t go to the doctor unless it’s unavoidable....


medicaldaily.com > camzyos-mavacamten-fda-approval-teens-obstructive-hcm-479527

Teens with Obstructive Hypertrophic Cardiomyopathy Gain Their First FDA-Approved Treatment as Camzyos Approval Expands Beyond Adults

3+ hour, 59+ min ago   (733+ words) Children with a thickened, blocked heart muscle now have their first FDA-approved treatment to improve their ability to be active and reduce their symptoms. The Food and Drug Administration on Sept. 30 approved Camzyos (mavacamten) for pediatric patients weighing at least…...


newsindiatimes.com > scientists-led-by-indian-american-identify-biological-mechanism-that-may-explain-obesity-relapse

Scientists, Led By Indian American, identify biological mechanism that may explain obesity relapse

2+ hour, 13+ min ago   (610+ words) New research explains why weight regain is common after dieting or stopping GLP-1 medications; Researchers discovered that obesity creates a lasting “memory” in fat cells that keeps hunger signals elevated even after weight loss; Obesity “memory” can be passed from…...


insurancebusinessmag.com > us > news > benefits > most-postpartum-glp1-starters-had-no-qualifying-diagnosis-us-study-finds-592296.aspx

Most postpartum GLP-1 starters had no qualifying diagnosis, US study finds

9+ hour, 13+ min ago   (249+ words) Most employer GLP-1 coverage policies are built around a clinical trigger: a diagnosis of type 2 diabetes, obesity, or a related condition that justifies the prescription. A new study published in JAMA suggests that in the postpartum population, that framework is…...


healthline.com > health-news > increase-ozempic-dose-lower-heart-events-mounjaro

Increasing Ozempic Dose Linked to Lower Heart Risk Than Switching to Mounjaro

1+ hour, 53+ min ago   (532+ words) Increasing the dose of Ozempic rather than switching to Mounjaro may be associated with a lower risk of major adverse cardiovascular events (MACE), according to a 2026 insurance claims analysis presented at the European Association for the Study of Diabetes (EASD)…...


oskynews.org > mahaska-health-offers-personalized-medical-help-for-weight-loss

Mahaska Health Offers Personalized Medical Help for Weight Loss

3+ hour, 22+ min ago   (20+ words) Oskaloosa News Mahaska Health Offers Personalized Medical Help for Weight Loss...


aol.co.uk > articles > tv-doctor-explains-science-behind-160000000.html

TV doctor explains the science behind 5 common symptoms you may experience every day

1+ hour, 44+ min ago   (449+ words) Dr Amir Khan is a familiar face on ITV's Lorraine and other programmes, and posted a video on TikTok outlining a series of common symptoms that he said "feel totally random, but actually have a proper medical explanation". He said:…...


realitytea.com > 10/05/2026 > donald-trump-aspirin-daily-dose-psychological-reason

Donald Trump Says Doctors Want Him to Change a 35-Year Daily Habit

4+ hour, 11+ min ago   (300+ words) President Donald Trump has revealed that his doctors want him to change a daily routine he has maintained for decades. Trump has discussed his long-standing aspirin use and the reason he has continued with the same dosage despite medical advice…...


louisianaradionetwork.com > 10/05/2026 > 48423

According to new report, Louisiana is making great strides in reducing state’s adult obesity rate

3+ hour, 11+ min ago   (147+ words) Jesper Sehested / CC “I think I have a very clear answer. It’s the availability and the increasing rates of using GLP-1 receptor agonist drugs,” Rom said. Dr. Rom says the benefits of the GLP-1 drugs, which are becoming more and…...